BILIARY TRACT CANCER (BTC)
Clinical trials for BILIARY TRACT CANCER (BTC) explained in plain language.
Never miss a new study
Get alerted when new BILIARY TRACT CANCER (BTC) trials appear
Sign up with your email to follow new studies for BILIARY TRACT CANCER (BTC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for bile duct cancer: drug duo targets tough tumors
Disease control Not yet recruitingThis phase II trial tests a combination of two drugs—Becotatug vedotin (a targeted therapy) and pucotenlimab (an immunotherapy)—in 30 adults with advanced biliary tract cancer whose first treatment stopped working. The goal is to see if the combo can shrink tumors and improve sur…
Matched conditions: BILIARY TRACT CANCER (BTC)
Phase: PHASE2 • Sponsor: HuiKai Li • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Radiation plus immunotherapy shows promise in bile duct cancer trial
Disease control Not yet recruitingThis study tests whether adding targeted radiation (SBRT) to standard chemotherapy and immunotherapy can help people with advanced bile duct cancer live longer without their cancer growing. About 123 adults with untreated, inoperable bile duct cancer will be randomly assigned to …
Matched conditions: BILIARY TRACT CANCER (BTC)
Phase: PHASE2 • Sponsor: Eastern Hepatobiliary Surgery Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
New drug cocktail aims to tame deadly bile duct cancer
Disease control Not yet recruitingThis study tests a combination of two immunotherapy drugs (iparomlimab and toripalimab) plus bevacizumab and chemotherapy as a first treatment for advanced biliary tract cancer. It involves 32 adults aged 18-75 who have not had prior treatment for their advanced cancer. The goal …
Matched conditions: BILIARY TRACT CANCER (BTC)
Phase: PHASE4 • Sponsor: Xianglin Yuan • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
New hope for bile duct cancer: combo therapy aims to boost survival
Disease control Not yet recruitingThis study tests whether adding the drug Mitazalimab to standard chemotherapy helps people with advanced bile duct cancer live longer. About 160 adults whose cancer has spread or cannot be removed will receive either chemo alone or chemo plus Mitazalimab. Researchers will check s…
Matched conditions: BILIARY TRACT CANCER (BTC)
Phase: PHASE2, PHASE3 • Sponsor: UNICANCER • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Herbal pill may ease cancer treatment burden
Symptom relief Not yet recruitingThis study tests whether adding a traditional Chinese herbal pill called Yueju to standard cancer therapy can improve quality of life for people with advanced biliary tract cancer. About 210 adults will be randomly assigned to get either the pill or a placebo, without knowing whi…
Matched conditions: BILIARY TRACT CANCER (BTC)
Phase: NA • Sponsor: Fudan University • Aim: Symptom relief
Last updated Jun 26, 2026 16:24 UTC
-
Old tumor samples may hold key to future biliary cancer treatments
Knowledge-focused Not yet recruitingThis study will examine stored tumor samples from 244 people diagnosed with biliary tract cancer in the last 15 years. Researchers will measure five specific markers (CLDN18.2, HER2, TROP2, PD-L1, and B7-H4) to see how common they are and how they relate to patient outcomes. The …
Matched conditions: BILIARY TRACT CANCER (BTC)
Sponsor: MedSIR • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:04 UTC
-
Blood tests and patient surveys could improve bile duct cancer monitoring
Knowledge-focused Not yet recruitingThis study aims to learn if blood tests for cancer DNA (ctDNA) and patient-reported quality of life can help doctors predict how bile duct cancer will progress and whether treatments are working. Researchers will collect blood samples and surveys from 300 patients with curable or…
Matched conditions: BILIARY TRACT CANCER (BTC)
Sponsor: Aarhus University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:11 UTC